{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:56:47Z","timestamp":1787007407235,"version":"build-2736575974"},"reference-count":101,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,3,16]]},"DOI":"10.1080\/14796694.2025.2464494","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T04:30:01Z","timestamp":1739334601000},"page":"815-831","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Asciminib in the treatment of chronic myeloid leukemia in chronic phase"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-2936","authenticated-orcid":false,"given":"Alessandro","family":"Costa","sequence":"first","affiliation":[{"name":"University of Cagliari","place":["Cagliari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Scalzulli","sequence":"additional","affiliation":[{"name":"Az. Policlinico Umberto I-Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Bisegna","sequence":"additional","affiliation":[{"name":"Az. Policlinico Umberto I-Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-6162","authenticated-orcid":false,"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[{"name":"Az. Policlinico Umberto I-Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0780-6"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01040"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.73"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001329"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02187-w"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3071"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24247"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.02.025"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221531"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.09.011"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178790"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18359"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02159-0"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3343"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.3139re6"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01586.x"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184210"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3897.bloodjournal86103897"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8438166"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(03)00274-0"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00194-6"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.13.12.7587"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.21.12779"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3180729"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb00214.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/351400a0"},{"issue":"1","key":"e_1_3_4_33_1","first-page":"208","article-title":"P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia","volume":"8","author":"Melo JV","year":"1994","unstructured":"Melo JV, Myint H, Galton DA, et al. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia. Leukemia. 1994;8(1):208\u2013211.","journal-title":"Leukemia"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-00766-w"},{"issue":"15","key":"e_1_3_4_36_1","first-page":"4236","article-title":"Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)1","volume":"62","author":"Nagar B","year":"2002","unstructured":"Nagar B, Bornmann WG, Pellicena P, et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)1. Cancer Res. 2002;62(15):4236\u20134243.","journal-title":"Cancer Res"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb500696t"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601912462126"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1486"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36956-5"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.166"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029828"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2010.01054.x"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301581y"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00073"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140968"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106458"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02314-7"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.026633"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08675"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21702"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709662105"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111451118"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24393"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.264"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2019.03.018"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022538"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102238"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.004"},{"issue":"9","key":"e_1_3_4_60_1","first-page":"4470","article-title":"Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1\n                  T315I-compound mutations","volume":"11","author":"Gleixner KV","year":"2021","unstructured":"Gleixner KV, Filik Y, Berger D, et al. Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1T315I-compound mutations. Am J Cancer Res. 2021;11(9):4470\u20134484.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133597"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01860-w"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02278-8"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024657"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201218"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009984"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-186854"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400858"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000974704.58510.92"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200017"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902328"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2699"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.7000"},{"issue":"1","key":"e_1_3_4_74_1","first-page":"1261","article-title":"Propensity score matching analysis comparing asciminib versus ponatinib for its treatment outomes in chronic myeloid leukemia patients","volume":"8","author":"Perusini MA","year":"2024","unstructured":"Perusini MA, Kockerols C, \u017d\u00e1\u010dkov\u00e1 D, et al. Propensity score matching analysis comparing asciminib versus ponatinib for its treatment outomes in chronic myeloid leukemia patients. HemaSphere. 2024;8(S1):1261\u20131262.","journal-title":"HemaSphere"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04562-5"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04932-6"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181937"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02411-7"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00420-8"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.16446"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000969648.55133.e1"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e18519"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.080234"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01680-9"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-209537"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1214"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000561812.22500.d8"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000561816.04574.8b"},{"key":"e_1_3_4_89_1","unstructured":"Food and Drug Administration. FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia [Internet]. 2024 [cited 2025 Jan 10]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-asciminib-newly-diagnosed-chronic-myeloid-leukemia"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967536.34543.a6"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-167177"},{"issue":"1","key":"e_1_3_4_92_1","first-page":"1268","article-title":"(P730) Asciminib as initial therapy for patients with chronic myeloid leukemia in chronic phase","volume":"8","author":"Atallah EL","year":"2024","unstructured":"Atallah EL, Mauro M, Thompson J, et al. (P730) Asciminib as initial therapy for patients with chronic myeloid leukemia in chronic phase. HemaSphere. 2024;8(S1)):1268\u20131269.","journal-title":"HemaSphere"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157002"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2024.2402680"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200717"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy159"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19269"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041045"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.6563"},{"key":"e_1_3_4_100_1","unstructured":"European Medicines Agency. Asciminib (Scemblix) [Internet]. 2024 [cited 2025 Jan 12]. Available from:. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/scemblix"},{"key":"e_1_3_4_101_1","unstructured":"Therapeutic goods administration. Asciminib (Sclemblix) [Internet]. 2024 [cited 2025 Jan 12]. https:\/\/www.tga.gov.au\/news\/safety-updates\/product-information-safety-updates-october-2024"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181391"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-205300"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2464494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:47:36Z","timestamp":1770911256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2464494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":101,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,3,16]]}},"alternative-id":["10.1080\/14796694.2025.2464494"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2464494","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}